[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523604":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":34,"responsibleParty":60,"collaborators":19,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":67,"acronym":19,"eligibilityCriteria":68,"healthyVolunteers":65,"sex":69,"minAge":70,"maxAge":19,"enrollmentInfo":71,"targetDuration":19,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":82,"overallStatus":36,"whyStopped":19,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Northwell Health","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Transcranial Ultrasound","EXPERIMENTAL","Ultrasound imaging will be performed by clinicians using FDA-approved ultrasound devices currently used in routine clinical practice.",[13],"Diagnostic Test: Transcranial Ultrasound",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Patients who underwent reconstructive sonolucent cranioplasty will receive standard of care postoperative imaging (i.e. CT, MRI) in addition to ultrasound imaging. Ultrasound imaging will be performed by clinicians using FDA-approved ultrasound devices (GE Venue Go, Fujifilm Sonosite X-Porte, GE Volusion E10 and Clarius HD3 etc.) currently used in routine clinical practice.",[9],null,[21],{"name":22,"affiliation":23,"role":24},"Netanel Ben-Shalom, MD","Lenox Hill Hospital","PRINCIPAL_INVESTIGATOR",[26,30],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},"CONTACT","212-434-3900","nbenshalom@northwell.edu",{"name":31,"role":27,"phone":32,"phoneExt":19,"email":33},"Tamika Wong, MPH","212-434-4836","twong4@northwell.edu",[35],{"facility":23,"status":36,"city":37,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","New York","10075","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-74.00597,40.71427,{"lat":45,"lon":44},[48,49,50,53,55,57,59],{"name":22,"role":27,"phone":28,"phoneExt":19,"email":29},{"name":31,"role":27,"phone":32,"phoneExt":19,"email":33},{"name":51,"role":52,"phone":19,"phoneExt":19,"email":19},"Randy D'Amico, MD","SUB_INVESTIGATOR",{"name":54,"role":52,"phone":19,"phoneExt":19,"email":19},"Heustein Sy, MD",{"name":56,"role":52,"phone":19,"phoneExt":19,"email":19},"Vadim Zhigin, PA",{"name":58,"role":52,"phone":19,"phoneExt":19,"email":19},"Olivia Albers, NP",{"name":31,"role":52,"phone":19,"phoneExt":19,"email":19},{"type":24,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"Netanel Ben-Shalom","Principal Investigator","100523604","transcranial-ultrasound-via-sonolucent-cranioplasty-100523604",false,"NCT06097845","Transcranial Ultrasound Via Sonolucent Cranioplasty","Inclusion Criteria:\n\n1. Provision of signed and dated informed consent form.\n2. Stated willingness to comply with all study procedures and availability for the duration of the study.\n3. Patients who are undergoing reconstructive sonolucent cranioplasty as standard of care.\n4. Male or female, aged ≥ 18.\n\nExclusion Criteria:\n\n1\\. Patients who are pregnant","ALL","18 Years",{"count":72,"type":73},50,"ESTIMATED","INTERVENTIONAL",[76],"NA","Transcranial Ultrasound via Sonolucent Cranioplasty is a prospective, single arm, observational, open label (non-blinded) study to collect real world evidence on the use of transcranial ultrasound via sonolucent cranioplasty.",[79,80,81],"Cranioplasty","Sonolucent Cranioplasty","Reconstructive Cranioplasty",[9,83,84],"SOC ultrasound","PMMA implant","2025-09-11",{"date":87,"type":88},"2025-09-15","ACTUAL",{"date":90,"type":88},"2023-06-27",{"date":92,"type":73},"2028-12-31",{"name":5,"class":6},1]